PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · News & media

Novo Nordisk CEO Sees Weight-Loss Market Expanding as Wegovy Pill Goes on Sale

News & media7:25Dec 2025

Today’s cheapest semaglutide pill$199/mo at RxSpan MD on a 6-month plan.Compare all semaglutide pill prices Price read 14 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this Bloomberg interview, Novo Nordisk CEO the speaker discusses the launch of the Wegovy pill in the U.S. The interviewer notes that Novo has been losing share to Eli Lilly in recent years and asks how the company will use its head start, since the pill is expected to be on sale in January and Lilly's oral version is not due until March. The speaker says the company will go all in to make the launch a success.

Published by Bloomberg Podcasts on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

He says the pill offers 17% efficacy when taken regularly, and that one in three people will reduce their weight by up to 20%. According to him, no other phase three trial of an oral GLP-1 has shown this level of efficacy, so people no longer have to choose between an effective injection and a convenient pill. He also points to more than 10 years of safety data and says the pill offers cardiovascular protection.

The speaker says Novo has shown it can put a peptide into a pill and produce it at scale, and that it can supply every person who wants it. He says the price will start at $149, and he expects the market to expand because some people avoid GLP-1 treatment out of fear or stigma around injections. He also says Novo intends to keep pursuing deals to strengthen its pipeline in diabetes and obesity, citing close to 2 billion people affected by diabetes and overweight.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The interviewer says Novo expects to sell the Wegovy pill in January, ahead of Eli Lilly's oral version, which is not due until March.
  2. 0:33 The speaker says the pill has 17% efficacy when taken regularly, and one in three people will lose up to 20% of their weight.
  3. 3:08 He says Novo has shown it can scale a peptide pill and is ready to supply everyone who wants it.
  4. 4:43 He expects the market to grow because people who avoided injections may now consider the pill.
  5. 5:49 He says pricing starts at $149 and that Novo plans to keep pursuing deals in diabetes and obesity.

Key moments

Tap one to play from there.

  1. 0:00 Wegovy pill approval
  2. 1:04 Competing in the GLP-1 market
  3. 2:20 Distribution and channels
  4. 3:00 Scaling production and supply
  5. 4:27 Market expansion opportunities
  6. 5:30 Pricing and political landscape
  7. 6:24 Future M&A and pipeline goals

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy

Questions this video answers

How effective is the Wegovy pill according to Novo Nordisk's CEO?

The speaker says the pill has 17% efficacy when taken regularly. He adds that one in three people will reduce their weight by up to 20%.

How much will the Wegovy pill cost?

The speaker says the announced price starts at $149. He describes this as affordable for many Americans.

When will the Wegovy pill launch compared with Eli Lilly's pill?

The interviewer says Novo expects to sell the Wegovy pill in January, while Eli Lilly's version is not due until March.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • How to get Wegovy, online or in person: the criteria, the prescriber, the tablet, and what each route costs

    You can get Wegovy online: any licensed prescriber can write it by video, and Novo's own NovoCare Pharmacy ships the pen or the daily tablet to your door. You qualify as an adult with obesity, or overweight plus a weight-related condition, or with heart disease. Paying is the variable: $25 with covered commercial insurance and Novo's card, $50 on Medicare's GLP-1 Bridge, $349 a month for the pen or from $149 for the tablet direct from Novo, and compounded semaglutide from $39 on our board.

  • The Wegovy pill: what it costs, how well it works and how it compares with the pen

    The Wegovy pill is a once-a-day semaglutide tablet for weight loss, FDA-approved and on sale since January 2026. Paying cash, Novo Nordisk charges $149 a month at the starting dose, $199 at the second step and $299 at the higher doses, against $349 a month for the Wegovy pen. In its main trial, people on the full-strength tablet lost 13.6% of their body weight on average over 64 weeks.

  • Wegovy pill vs injection: the same semaglutide, two schedules, two price lists

    The Wegovy pill and the Wegovy pen are the same drug, semaglutide. The pill is one tablet a day on an empty stomach with a little water; the pen is one injection a week at any time. Novo's cash price is $149 to $299 a month for the pill by strength and $349 for the pen. In separate placebo trials the top tablet dose and the pen produced similar average weight loss.

Next steps

Wegovy pill prices

Find more like it

Injection techniqueCost and insurance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV